what’s on the horizon for higher-risk mds? an update on emerging novel agents?
Published 1 year ago • 117 plays • Length 33:55Download video MP4
Download video MP3
Similar videos
-
57:07
higher-risk mds and newly diagnosed aml: what are the latest developments from eha 2022?
-
3:24
novel agents in higher-risk mds
-
3:31
promising treatment options emerging for higher-risk mds & the value of clinical trials
-
1:27
exciting updates in higher-risk mds at ash 2022
-
1:21
future treatment priorities for high-risk mds
-
47:01
advancing the management of mds and aml: novel immune-based approaches
-
1:41
novel therapies for high-risk mds
-
45:19
healthcare isn't ready for what's coming...
-
1:08:02
what every patient with myelodysplastic syndrome(s) should know 2018
-
35:50
a husband's perspective on wife's xanax withdrawal: inspiration for benzoreform.org
-
0:59
the current challenges facing high-risk mds treatment
-
1:14
novel therapies on the horizon for mds
-
1:17
how is higher-risk mds-related anemia treated?
-
6:05
the immune system's role in higher-risk mds
-
51:49
what's new in mds may 19 2021
-
4:26
promising therapies on the horizon for mds
-
1:39
current landscape and future directions for lower-risk mds treatment
-
0:38
what's on the horizon with research in this area?
-
3:36
what are mds risk factors? #mds
-
1:22:01
current challenges and unmet medical needs in mds: new approaches for anemia in mds
-
1:19
future directions in mds
-
1:27
novel targets in low-risk mds